Plasma Supply Falling Behind Demand: Kristopher Jonas Sounds the Alarm
Kristopher Jonas, CEO/President of Proesis Biologics, posted on LinkedIn:
”You know what’s scary?
The growing gap between how much plasma-derived medicine the world needs and how much plasma we’re actually collecting.
Global demand for immunoglobulins (IG) continues to climb 6–8% each year. And that’s not even factoring in underutilization in low to middle-income countries.
Fractionators are bringing new manufacturing capacity online across the U.S. and Europe.
But all that capacity still depends on one thing – human plasma – and the supply side isn’t keeping pace.
That’s where independent collectors come in.
We’re the flexible link in the chain, able to expand quickly, reach new donor communities, and help ensure the growing global infrastructure doesn’t sit idle waiting for plasma.
Not spooky. Just real.
And it’s why what we’re building at Proesis Bio matters.”
Keep up with Hemostasis Today.
-
May 24, 2026, 17:48Flora Peyvandi: Crucial Role of Placental ADAMTS13 in Perinatal Survival
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration